Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01624766
Title Anakinra or Denosumab and Everolimus in Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

Advanced Solid Tumor


Denosumab + Everolimus

Anakinra + Everolimus

Age Groups: adult
Covered Countries USA

No variant requirements are available.